Your browser doesn't support javascript.
loading
Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.
Chandra, Janin; Hansen, Morten; Labarriere, Nathalie; Marigo, Ilaria; Souza-Fonseca-Guimaraes, Fernando; Vujanovic, Lazar; Koguchi, Yoshinobu; Jacquelot, Nicolas.
Afiliação
  • Chandra J; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
  • Hansen M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Labarriere N; Nantes Université, Université Angers, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302., Nantes, France.
  • Marigo I; LabEx IGO, Université de Nantes, Nantes, France.
  • Souza-Fonseca-Guimaraes F; Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
  • Vujanovic L; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Koguchi Y; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
  • Jacquelot N; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, United States.
Front Immunol ; 13: 939789, 2022.
Article em En | MEDLINE | ID: mdl-35720421
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenômenos Bioquímicos / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenômenos Bioquímicos / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article